Literature DB >> 3042649

Excess risk of sickness and disease in bus drivers: a review and synthesis of epidemiological studies.

M A Winkleby1, D R Ragland, J M Fisher, S L Syme.   

Abstract

In an extensive search of available literature, 22 epidemiological studies that have examined health risks of bus drivers were identified. These studies focus on three main disease categories: (1) cardiovascular disease, including hypertension, (2) gastrointestinal illnesses, including peptic ulcer and digestive problems, and (3) musculoskeletal problems including back and neck pain. The studies consistently report that bus drivers have higher raes of mortality, morbidity, and absence due to illness when compared to employees from a wide range of other occupational groups. Increased disease rates have been found for drivers regardless of the use of different research methodologies, measurement techniques and comparison groups. When evaluating the impact of bias on the estimates of risk, it appears likely that findings are conservative: strong systematic selective factors have probably favoured the elimination of those in poorer health both at the time of entry into and exit from the job of bus driving and other sources of bias have most likely caused underestimations of risk. Nevertheless, there remain questions that need careful assessment before firm conclusions can be made about whether increased disease rates result from driving a bus. Such questions, coupled with the consistent findings of heightened risk of disease, make urban bus drivers an appropriate and promising occupational group in which to study further the potential adverse effects of the work environment on employee health.

Entities:  

Mesh:

Year:  1988        PMID: 3042649     DOI: 10.1093/ije/17.2.255

Source DB:  PubMed          Journal:  Int J Epidemiol        ISSN: 0300-5771            Impact factor:   7.196


  20 in total

1.  Hospital admissions among male drivers in Denmark.

Authors:  H Hannerz; F Tüchsen
Journal:  Occup Environ Med       Date:  2001-04       Impact factor: 4.402

2.  Job strain and blood pressure in African Americans: the Pitt County Study.

Authors:  A B Curtis; S A James; T E Raghunathan; K H Alcser
Journal:  Am J Public Health       Date:  1997-08       Impact factor: 9.308

3.  Driving with diabetes in the future: in-vehicle medical monitoring.

Authors:  David Kerr; Tolulope Olateju
Journal:  J Diabetes Sci Technol       Date:  2010-03-01

Review 4.  Cardiovascular dysfunction related to threat, avoidance, and vigilant work: application of event-related potential and critique.

Authors:  R Emdad; K Belkic; T Theorell
Journal:  Integr Physiol Behav Sci       Date:  1997 Jul-Sep

5.  Job hassles and cardiovascular reaction patterns among urban bus drivers.

Authors:  G Johansson; G W Evans; L W Rydstedt; S Carrere
Journal:  Int J Behav Med       Date:  1998

6.  Job strain and prevalence of hypertension in a biracial population of urban bus drivers.

Authors:  C L Albright; M A Winkleby; D R Ragland; J Fisher; S L Syme
Journal:  Am J Public Health       Date:  1992-07       Impact factor: 9.308

7.  Smoking and all-cause mortality among a cohort of urban transit operators.

Authors:  Robert Lipton; Carol Cunradi; Meng-Jinn Chen
Journal:  J Urban Health       Date:  2008-06-14       Impact factor: 3.671

8.  Comparison between two programmes for reducing the levels of risk indicators of heart diseases among male professional drivers.

Authors:  G E Hedberg; L Wikström-Frisén; U Janlert
Journal:  Occup Environ Med       Date:  1998-08       Impact factor: 4.402

9.  Electrocortical signs of arousal in response to darkness and the assessment of Type A behavior in professional drivers with and without cardiovascular disease.

Authors:  R Emdad
Journal:  Integr Physiol Behav Sci       Date:  1998 Jul-Sep

10.  Worksite environment intervention to prevent obesity among metropolitan transit workers.

Authors:  Simone A French; Lisa J Harnack; Peter J Hannan; Nathan R Mitchell; Anne F Gerlach; Traci L Toomey
Journal:  Prev Med       Date:  2010-01-14       Impact factor: 4.018

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.